SCHEMBL21088593

SCHEMBL21088593

COC1=CC(Nc2ccc3c4c(n(C(=O)OC(C)(C)C)c3c2)CCC(N(C)C(=O)OC(C)(C)C)C4)=CCC1OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12128127 0.83 PDE4B (0.35) —
SCHEMBL12131830 0.77 AKR1C3 (0.36) —
SCHEMBL12127652 0.76 HTR6 (0.40) —
SCHEMBL12131768 0.75 HTR6 (0.38) —
SCHEMBL12131755 0.75 HTR6 (0.38) —
SCHEMBL12128199 0.73 APP (0.35) —
SCHEMBL21088212 0.72 HTR6 (0.34) —
SCHEMBL12127557 0.71 HTR6 (0.46) —
SCHEMBL12128235 0.71 APP (0.37) —
SCHEMBL12132037 0.70 SCN9A (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558446-B1 NOVEL COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS AC IMMUNE SA (CH) 2019-06-12 — — EP disclosed
Send feedback